Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics Inc (NQ: IOVA )

8.205 +0.245 (+3.08%)
Streaming Delayed Price Updated: 2:45 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,222,555
Open 8.070
Bid (Size) 8.200 (23)
Ask (Size) 8.210 (18)
Prev. Close 7.960
Today's Range 8.000 - 8.240
52wk Range 3.210 - 18.33
Shares Outstanding 279,832,722
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About Iovance Biotherapeutics?
Via Benzinga
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+1.30%
+1.30%
1 Month
+2.43%
+2.43%
3 Month
-27.52%
-27.52%
6 Month
+1.55%
+1.55%
1 Year
+11.33%
+11.33%

More News

Read More
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
Via InvestorPlace
Is Iovance Biotherapeutics a Millionaire Maker?
Via The Motley Fool
3 Under-$10 Biotech Stocks That Could Make You Rich
Via InvestorPlace
What's Going On With Iovance Biotherapeutics Today?
Via Benzinga
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Is It Too Late to Buy Iovance Biotherapeutics Stock?
Via The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
Via InvestorPlace
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
Via The Motley Fool
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
Via News Direct
Exposures Product Safety
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Via The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
4 Small-Cap Value Stocks That Could Go Parabolic
Via The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
Via InvestorPlace
Why Iovance Stock Is Down 18% Today
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.